Update on paediatric antiretrovirals
1 August 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Conference reports
Is d4T a viable option for children in low-income countries?
1 August 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
3TC or FTC monotherapy suboptimal as a bridging strategy for adolescents
1 August 2014. Related: Conference reports, Paediatric care.
Rationalising the paediatric antiretroviral formulary in Malawi
1 August 2014. Related: Conference reports, Treatment access, Paediatric care.
Time to first-line failure in the IeDEA cohort
1 August 2014. Related: Conference reports, Paediatric care.
Influence of early ART on antibody detection in children
1 August 2014. Related: Conference reports, Paediatric care.
8th International Workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource-Poor Settings (INTEREST), 5-6 May 2014, Lusaka, Zambia
1 August 2014. Related: Conference reports.
Short-term safety of atazanavir/ritonavir-based second line treatment in Zambia
1 August 2014. Related: Conference reports, Antiretrovirals.
Pregnancy outcomes in Zambia
1 August 2014. Related: Conference reports, Pregnancy.
Uptake of ART is influenced by distance to the health facility in rural Zambia
1 August 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Genotyping using dried blood spots in rural South African setting
1 August 2014. Related: Conference reports, Drug resistance.
49th Annual Meeting of the European Association for the Study of the Liver (EASL 2014), 9-13 April 2014, London
27 May 2014. Related: Conference reports.
Activists protest the price of sofosbuvir: “So-Valdi, So-Expensive” – UK access already rationed
27 May 2014. Related: Conference reports, Treatment access.
EASL 2014: summary of interferon-free HCV studies with new DAAs
27 May 2014. Related: Conference reports, Other news.
WHO launch treatment guidelines for hepatitis C (2014)
27 May 2014. Related: Conference reports, Guidelines, Hepatitis coinfection.
3rd Joint Conference of BHIVA/BASHH, 1-4 April 2014, Liverpool
27 May 2014. Related: Conference reports.
50% of UK seroconverters start ART within 1.4 years of infection: treating during primary infection should be a patient choice
27 May 2014. Related: Conference reports, Antiretrovirals, Treatment strategies.
PIVOT study: further analysis from five-year PI/r monotherapy strategy study
27 May 2014. Related: Conference reports, Antiretrovirals, Treatment strategies.
Sexually transmitted HCV in HIV positive and negative gay men
27 May 2014. Related: Conference reports, Hepatitis coinfection.
Annual HCV testing and use of core antigen to reduce costs and increase diagnosis during acute HCV
27 May 2014. Related: Conference reports, Hepatitis coinfection.
HIV positive attitudes to involvement as donors and recipients in organ transplant programmes
27 May 2014. Related: Conference reports.
21st Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014, Boston
27 May 2014. Related: Conference reports.
Pharmacokinetics of antiretrovirals in pregnancy
27 May 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Better virologic outcomes with efavirenz vs lopinavir/ritonavir in pregnant women and no difference in risk of preterm birth
27 May 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Once daily lopinavir/ritonavir not recommended for routine use in children and adolescents
27 May 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Early antiretroviral treatment in infants
27 May 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Hospitalisation among elite controllers
27 May 2014. Related: Conference reports, Treatment strategies.
Catching up with pathogenesis and cure research from CROI 2014
27 May 2014. Related: Conference reports, Paediatric care, Cure-related research.
21st Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014, Boston
24 March 2014. Related: Conference reports.
No HIV transmissions with undetectable viral load: interim PARTNER study results show need for longer follow-up
24 March 2014. Related: Conference reports, HIV prevention and transmission.
PrEP injections every three months may protect against exposure from anal sex
24 March 2014. Related: Conference reports, HIV prevention and transmission.
ARV pipeline: doravirine, GSK-744 and BMS-068
24 March 2014. Related: Conference reports, Antiretrovirals.
Viral load rebound rate of 35% using ritonavir-boosted PI monotherapy: results of five-year PIVOT study
24 March 2014. Related: Conference reports, Antiretrovirals, Treatment strategies.
Dual therapy less effective at high viral load: NEAT 001 study with raltegravir/darunavir/r
24 March 2014. Related: Conference reports, Antiretrovirals, Treatment strategies.
Atazanavir, raltegravir and darunavir virologically equivalent in naive patients but significant differences for tolerability: results from ACTG 5257
24 March 2014. Related: Conference reports, Antiretrovirals, Treatment strategies.
Pharmacokinetic targets for efavirenz might be too high
24 March 2014. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Abacavir link to cardiovascular events in high-risk patients maintained in D:A:D study
24 March 2014. Related: Conference reports, Side effects.
NNRTI resistance found in 12% of people stopping treatment with undetectable viral load: implications for stock-outs
24 March 2014. Related: Conference reports, Treatment strategies, Drug resistance.
HIV related infections remain the leading cause of maternal deaths in South Africa despite the availability of ART
24 March 2014. Related: Conference reports, Pregnancy.
Lower newborn bone mineral content with maternal tenofovir use
24 March 2014. Related: Conference reports, Pregnancy.
Paediatric pipeline: CROI 2014 update on new antiretrovirals for children
24 March 2014. Related: Conference reports, Paediatric care.
Efavirenz maintenance therapy effective in children exposed to nevirapine prophylaxis
24 March 2014. Related: Conference reports, Paediatric care.
Xpert TB test has important advantages but does not reduce morbidity
24 March 2014. Related: Conference reports, TB coinfection.
Reports of a second baby possibly cured of HIV: uncertainty remains
24 March 2014. Related: Conference reports, Cure-related research, Basic science and immunology.
Updates on SB728-T, a CCR5-targeting gene therapy
24 March 2014. Related: Conference reports, Cure-related research, Basic science and immunology.
4th International Workshop on HIV & Women, 13-14 January 2014, Washington
1 February 2014. Related: Conference reports.
Women, HIV research and antiretrovirals
1 February 2014. Related: Conference reports, Antiretrovirals, Women's health, Cure-related research.
Improved virological outcomes for women starting efavirenz-based first-line regimens in South Africa
1 February 2014. Related: Conference reports, Women's health.
High rates of pregnancy in HIV positive women in Zambia and South Africa
1 February 2014. Related: Conference reports, Women's health, Pregnancy.
Contraceptive choices among a Canadian cohort of HIV positive women
1 February 2014. Related: Conference reports, Women's health.
Bone disease and older HIV positive women
1 February 2014. Related: Conference reports, Women's health.
Lower immune response to the qHPV vaccine in HIV positive girls
1 February 2014. Related: Conference reports, Women's health, Paediatric care.
HIV exposed vs unexposed babies have lower gestational age and birth weight in Danish study
1 February 2014. Related: Conference reports, Pregnancy, Paediatric care.
Outcomes in infants exposed to lopinavir/ritonavir in utero
1 February 2014. Related: Conference reports, Antiretrovirals, Pregnancy, Paediatric care.
17th International Conference on AIDS and STIs in Africa (ICASA), 7-11 December 2013, Cape Town
1 February 2014. Related: Conference reports.
Two percent rate of efavirenz discontinuation in an ART programme in Malawi
1 February 2014. Related: Conference reports, Antiretrovirals, Pregnancy, Side effects.
6th International Workshop on HIV Persistence During Therapy, 3-6 December 2013, Miami, USA
1 February 2014. Related: Conference reports.
Report from the 6th Workshop on HIV Persistence
1 February 2014. Related: Conference reports, Cure-related research.
44th Union World Conference on Lung Health, 30 October – 3 November 2013, Paris
1 December 2013. Related: Conference reports.
Preventing and treating TB in children – more baby steps
1 December 2013. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
14th European AIDS Conference (EACS), 16-19 October 2013, Brussels
1 December 2013. Related: Conference reports.
Dolutegravir superior to darunavir/r at week 48 in open label treatment naïve study
1 December 2013. Related: Conference reports, Antiretrovirals.
GSK744: 24-week results with oral integrase inhibitor planned for once-monthly injections
1 December 2013. Related: Conference reports, Antiretrovirals.
Cenicriviroc: 48 week results compared to efavirenz
1 December 2013. Related: Conference reports, Antiretrovirals.
Approaches to once-daily raltegravir: new formulation likely to require food
1 December 2013. Related: Conference reports, Antiretrovirals.